Search results for: 'outsourcing ofstrive processing explos opportunities'

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

08 Jun 2022  |  North America  |  Market Research

Growth Opportunities in Sterile Injectable Outsourcing

Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing

Infographics

×

Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...

Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives for the global drug discovery and early development outsourcing market in this study, which covers research and development (R&D) efforts, market trends, key participants, drivers and restraints of market adoption, and recent mergers and acquisitions. The report ...

This research service provides an overview of the US revenue cycle management, revenue forecast, and competitive analysis of various legacy and modular RCM solutions. This study explores RCM applications across front-end, middle, and back-end processes and the end users are hospitals and ambulatory physician practices. In addition, it offers detail...

This research service on the global pharmaceutical stability testing market addresses market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year is 2015 and forecasts are provided from 2016 to 2020. The market is expected to grow at a CAGR of 9.4% till 2020, driven by an explosio...

In this analysis, Frost & Sullivan provides critical insights into the biotech M&A and venture capital (VC) investment, highlighting the drivers, challenges, predictions, and major trends in the biotech segment. This analysis also identifies actionable growth opportunities for industry participants to leverage. To understand the trend outlook fo...

21 May 2021  |  North America  |  Market Research

Explosion of Data Drives the US Social Determinants of Health Market

Proven Returns on Investment will Ignite Transformational Growth

Infographics

×

This report from Frost & Sullivan Healthcare and Life Sciences focuses on the potential to cater to healthcare needs based on data-driven social determinants of health (SDOH). Although the traditional practice of healthcare involves the use of medical technology and protocols to maintain and restore health, the SDOH concept adds another dimension. ...

30 Nov 2016  |  North America  |  Market Research

Third Party Sterilization Services for Care Providers in the US and Western Europe, Forecast to 2022

Hospitals are Increasingly Outsourcing their Surgical Instrument Sterilization - Next Frontier for Disinfection and Sterilization Equipment OEM?

Infographics

×

The study covers current and future market trends, drivers, and challenges in outsourcing of hospital sterile processing departments (SPD)/central sterile supply departments (CSSD) to specialized third party vendors. Despite being in the nascent phase, the third party sterilization services market generated total revenue of $1.4 billion in 2015 and...

This research service on the global cell banking market addresses market sizing, emerging trends, and technologies and provides a snapshot of the key participants in the market. The base year considered is 2015 and forecasts are provided from 2016 to 2020. The cell banking market is expected to grow at a CAGR of 16.7% till 2020, driven by special...